Regulatory Considerations for Fecal Microbiota Transplantation Products
Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in c...
Gespeichert in:
| Veröffentlicht in: | Cell host & microbe 2020-02, Vol.27 (2), p.173-175 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 175 |
|---|---|
| container_issue | 2 |
| container_start_page | 173 |
| container_title | Cell host & microbe |
| container_volume | 27 |
| creator | Carlson, Jr, Paul E |
| description | Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials. |
| doi_str_mv | 10.1016/j.chom.2020.01.018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2355960136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2355960136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-fac2b6ff8ef2bbb93f8dcb4cc098d0c84652e380a4641b421fd7c62e5a41cc693</originalsourceid><addsrcrecordid>eNo9kM1OwzAQhC0EoqXwAhxQjlwS1j9xnCOqaEEqAqFytmzHhlRJXezk0LcnaQvSSLuHmdHoQ-gWQ4YB84dNZr59mxEgkAEeJM7QFJeUpRx4eX74cUoxERN0FeMGIM-hwJdoQgnktBDFFC0_7FffqM6HfTL321hXNqiuHr7E-ZAsrFFN8lqb4HXtO5Wsg9rGXaO23cGVvAdf9aaL1-jCqSbam9Odoc_F03r-nK7eli_zx1VqKCu61ClDNHdOWEe01iV1ojKaGQOlqMAIxnNiqQDFOMOaEeyqwnBic8WwMbykM3R_7N0F_9Pb2Mm2jsY2wyLr-ygJzfOSA6Z8sJKjdRgfY7BO7kLdqrCXGOQIUG7kCFCOACXgQWII3Z36e93a6j_yR4z-Aivfbqc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2355960136</pqid></control><display><type>article</type><title>Regulatory Considerations for Fecal Microbiota Transplantation Products</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Carlson, Jr, Paul E</creator><creatorcontrib>Carlson, Jr, Paul E</creatorcontrib><description>Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.</description><identifier>ISSN: 1931-3128</identifier><identifier>EISSN: 1934-6069</identifier><identifier>DOI: 10.1016/j.chom.2020.01.018</identifier><identifier>PMID: 32053787</identifier><language>eng</language><publisher>United States</publisher><ispartof>Cell host & microbe, 2020-02, Vol.27 (2), p.173-175</ispartof><rights>Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-fac2b6ff8ef2bbb93f8dcb4cc098d0c84652e380a4641b421fd7c62e5a41cc693</citedby><cites>FETCH-LOGICAL-c347t-fac2b6ff8ef2bbb93f8dcb4cc098d0c84652e380a4641b421fd7c62e5a41cc693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32053787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carlson, Jr, Paul E</creatorcontrib><title>Regulatory Considerations for Fecal Microbiota Transplantation Products</title><title>Cell host & microbe</title><addtitle>Cell Host Microbe</addtitle><description>Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.</description><issn>1931-3128</issn><issn>1934-6069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kM1OwzAQhC0EoqXwAhxQjlwS1j9xnCOqaEEqAqFytmzHhlRJXezk0LcnaQvSSLuHmdHoQ-gWQ4YB84dNZr59mxEgkAEeJM7QFJeUpRx4eX74cUoxERN0FeMGIM-hwJdoQgnktBDFFC0_7FffqM6HfTL321hXNqiuHr7E-ZAsrFFN8lqb4HXtO5Wsg9rGXaO23cGVvAdf9aaL1-jCqSbam9Odoc_F03r-nK7eli_zx1VqKCu61ClDNHdOWEe01iV1ojKaGQOlqMAIxnNiqQDFOMOaEeyqwnBic8WwMbykM3R_7N0F_9Pb2Mm2jsY2wyLr-ygJzfOSA6Z8sJKjdRgfY7BO7kLdqrCXGOQIUG7kCFCOACXgQWII3Z36e93a6j_yR4z-Aivfbqc</recordid><startdate>20200212</startdate><enddate>20200212</enddate><creator>Carlson, Jr, Paul E</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200212</creationdate><title>Regulatory Considerations for Fecal Microbiota Transplantation Products</title><author>Carlson, Jr, Paul E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-fac2b6ff8ef2bbb93f8dcb4cc098d0c84652e380a4641b421fd7c62e5a41cc693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carlson, Jr, Paul E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell host & microbe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carlson, Jr, Paul E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulatory Considerations for Fecal Microbiota Transplantation Products</atitle><jtitle>Cell host & microbe</jtitle><addtitle>Cell Host Microbe</addtitle><date>2020-02-12</date><risdate>2020</risdate><volume>27</volume><issue>2</issue><spage>173</spage><epage>175</epage><pages>173-175</pages><issn>1931-3128</issn><eissn>1934-6069</eissn><abstract>Fecal microbiota for transplantation (FMT) is being studied as a potential intervention for numerous conditions. The regulation of FMT by the FDA is discussed along with FMT donor screening and manufacturing considerations. The FDA is committed to ensuring that FMT products can be safely tested in clinical trials.</abstract><cop>United States</cop><pmid>32053787</pmid><doi>10.1016/j.chom.2020.01.018</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1931-3128 |
| ispartof | Cell host & microbe, 2020-02, Vol.27 (2), p.173-175 |
| issn | 1931-3128 1934-6069 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2355960136 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| title | Regulatory Considerations for Fecal Microbiota Transplantation Products |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T14%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulatory%20Considerations%20for%20Fecal%20Microbiota%20Transplantation%20Products&rft.jtitle=Cell%20host%20&%20microbe&rft.au=Carlson,%20Jr,%20Paul%20E&rft.date=2020-02-12&rft.volume=27&rft.issue=2&rft.spage=173&rft.epage=175&rft.pages=173-175&rft.issn=1931-3128&rft.eissn=1934-6069&rft_id=info:doi/10.1016/j.chom.2020.01.018&rft_dat=%3Cproquest_cross%3E2355960136%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2355960136&rft_id=info:pmid/32053787&rfr_iscdi=true |